Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
McKesson
Mallinckrodt
Daiichi Sankyo
US Army
QuintilesIMS
Fuji
Queensland Health

Generated: April 26, 2018

DrugPatentWatch Database Preview

TYZINE Drug Profile

« Back to Dashboard

Which patents cover Tyzine, and when can generic versions of Tyzine launch?

Tyzine is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in TYZINE is tetrahydrozoline hydrochloride. There are two drug master file entries for this compound. Additional details are available on the tetrahydrozoline hydrochloride profile page.
Drug patent expirations by year for TYZINE
Synonyms for TYZINE
124638-40-0
1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, hydrochloride (1:1)
1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, monohydrochloride
2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline hydrochloride
2-(1,2,3,4-Tetrahydro-1-naphthyl)-2-imidazoline monohydrochloride
2-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)-4,5-DIHYDRO-1H-IMIDAZOLE HCL
2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole hydrochloride
2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole;hydrochloride
2-[(1RS)-1,2,3,4-Tetrahydronaphthalen-1-yl]-4,5-dihydro-1H-imidazole hydrochloride
2-IMIDAZOLINE, 2-(1,2,3,4-TETRAHYDRO-1-NAPHTHYL)-, HYDROCHLORIDE
2-tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
2-Tetralin-1-yl-4,5-dihydro-1H-imidazolehydrochloride
33067-94-6
4CH-023705
522-48-5
522T485
8059-87-8
84-22-0 (Parent)
AB0018230
AC-1110
AC1L1VND
AI3-50165
AK-45819
AKOS015899540
AN-165
AS-15973
BC209867
CAS-522-48-5
CCG-39268
CHEMBL1200413
CPD000058219
CS-2666
D01023
DSSTox_CID_25316
DSSTox_GSID_45316
DSSTox_RID_80797
DTXSID7045316
EINECS 208-329-3
EU-0101137
FT-0675067
HMS1570K17
HMS1921C21
HY-B0556A
I14-11410
K-9553
KS-00000N92
LP01137
LS-79684
MCULE-6434802156
MFCD00058029
MLS000069739
MLS000079025
MLS001146954
MLS002222291
MLS002548902
MolPort-000-720-037
Murine Plus
NC00484
NCGC00016018-10
NCGC00016485-01
NCGC00094403-01
NCGC00094403-02
NCGC00094403-03
NCGC00094403-04
NCGC00094403-05
NCGC00261822-01
NSC-757339
NSC757339
Opera_ID_1724
Pharmakon1600-01500567
Prestwick_1025
Q-201816
R615
S4043
SAM002264650
SCHEMBL25702
SMR000058219
SPECTRUM1500567
SR-01000000161
SR-01000000161-2
ST013854
ST24050142
T 4264
Tetrahydrozoline (hydrochloride)
Tetrahydrozoline HCl
Tetrahydrozoline hydrochloride
Tetrahydrozoline hydrochloride (JAN/USP)
Tetrahydrozoline hydrochloride [USAN:BAN]
Tetrahydrozoline hydrochloride, >=98%
Tetrahydrozoline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Tetrahydrozoline hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Tetrahydrozoline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Tetrahydrozoline nitrate
Tetryzoline HCl
Tetryzoline hydrochloride
Tetryzolini hydrochloridum
Tox21_110450
Tox21_110450_1
Tox21_501137
Tyzanol hydrochloride
Tyzine (TN)
Vasopos
visine hydrochloride
VU0239726-5
Z1695906783

US Patents and Regulatory Information for TYZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms TYZINE tetrahydrozoline hydrochloride SOLUTION;NASAL 086576-002 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms TYZINE tetrahydrozoline hydrochloride SOLUTION;NASAL 086576-001 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms TYZINE tetrahydrozoline hydrochloride SPRAY;NASAL 086576-003 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Julphar
McKinsey
Fish and Richardson
Johnson and Johnson
AstraZeneca
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.